Business Description
Anterogen Co Ltd
ISIN : KR7065660003
Compare
Compare
Traded in other countries / regions
065660.Korea IPO Date
2016-02-15Description
Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.17 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -20.11 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.53 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.9 | |||||
| 3-Year EBITDA Growth Rate | 48.5 | |||||
| 3-Year EPS without NRI Growth Rate | 4.2 | |||||
| 3-Year FCF Growth Rate | 40.6 | |||||
| 3-Year Book Growth Rate | 14.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.13 | |||||
| 9-Day RSI | 49.07 | |||||
| 14-Day RSI | 49.32 | |||||
| 6-1 Month Momentum % | 8.66 | |||||
| 12-1 Month Momentum % | -25.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.24 | |||||
| Quick Ratio | 5.06 | |||||
| Cash Ratio | 4.68 | |||||
| Days Inventory | 188.1 | |||||
| Days Sales Outstanding | 143.12 | |||||
| Days Payable | 74.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.3 | |||||
| Shareholder Yield % | 1.23 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.02 | |||||
| Operating Margin % | -78.06 | |||||
| Net Margin % | -43.7 | |||||
| FCF Margin % | -31.76 | |||||
| ROE % | -2.36 | |||||
| ROA % | -2.04 | |||||
| ROIC % | -5.54 | |||||
| ROC (Joel Greenblatt) % | -4.99 | |||||
| ROCE % | -1.04 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 21.8 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 1.14 | |||||
| EV-to-EBIT | -76.08 | |||||
| EV-to-EBITDA | -206.47 | |||||
| EV-to-Revenue | 15.39 | |||||
| EV-to-FCF | -48.45 | |||||
| Price-to-Projected-FCF | 3.56 | |||||
| Price-to-Net-Current-Asset-Value | 3.86 | |||||
| Price-to-Net-Cash | 4.63 | |||||
| Earnings Yield (Greenblatt) % | -1.31 | |||||
| FCF Yield % | -1.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anterogen Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 6,500.249 | ||
| EPS (TTM) (â‚©) | -298 | ||
| Beta | 1.42 | ||
| Volatility % | 39.17 | ||
| 14-Day RSI | 49.32 | ||
| 14-Day ATR (â‚©) | 561.443107 | ||
| 20-Day SMA (â‚©) | 14715.5 | ||
| 12-1 Month Momentum % | -25.37 | ||
| 52-Week Range (â‚©) | 12300 - 19820 | ||
| Shares Outstanding (Mil) | 9.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anterogen Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anterogen Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anterogen Co Ltd Frequently Asked Questions
What is Anterogen Co Ltd(XKRX:065660)'s stock price today?
The current price of XKRX:065660 is â‚©14450.00. The 52 week high of XKRX:065660 is â‚©19820.00 and 52 week low is â‚©12300.00.
When is next earnings date of Anterogen Co Ltd(XKRX:065660)?
The next earnings date of Anterogen Co Ltd(XKRX:065660) is .
Does Anterogen Co Ltd(XKRX:065660) pay dividends? If so, how much?
Anterogen Co Ltd(XKRX:065660) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers